Verve Therapeutics Inc.

05/10/2022 | Press release | Archived content

Verve Therapeutics Announces Clearance of First VERVE-101 Clinical Trial Application and Outlines Global Clinical Development Strategy; Reports First Quarter 2022 Financial Results